Clinical trial
Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder
NCT05399498
Study timeline
Study start (actual)2023-11-01Date precision: day
Registry last updated2025-12-23
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Borderline Personality Disorderunresolved
Major Depressive Disorderunresolved
Interventions
PsilocybinDRUG
Sponsors & collaborators
University of Chicagolead sponsor
Usona Institutecollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05399498 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.